Sales Contact
T: +33 1 4770 3024
Industry Publications

"Long Term Care for the Elderly in France, European Comparison", 2011

Industry Report published by Candesic, Deomenos and Epsilon Research

Click here for preview


> Order an Epsilon Market Report (starting at €950) > mail

NB: includes access to the underlying EMAT reports

Alert on Reports Published
Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.


Follow the sector on Twitter

Epsilon Research covers the M&A transactions for the "Health, Pharmaceuticals & Biotechnology" industry [960 EMAT Reports], which includes:


Our analysts publish transaction multiples reports for private company M&A deals (announced 2004 onwards).

Each report presents detailed information on the deal value, structure and rationale, the target's activity, history and financial information; it includes the calculation of the key historic and current multiples: enterprise value over sales (EV/S), EBITDA (EV/EBITDA), or EBIT (EV/EBIT), P/E and Price to Book. All information sources are systematically given and company financials are carefully verified and restated if needed.


The reports are a unique source of information to have a comparable metric for the valuation of a private company, establish the "market value" of an investment or private equity investment portfolios.


The deal reports are published in Epsilon's EMAT database.
For an example of EMAT report, please click on this link.
If you wish to buy an EMAT Report, and you are not a customer, please contact us.


Recent M&A Deal Reports Published on EMAT

Date Acquirer Target Country Industries Valuation multiples See details
25/06/2020 Novozymes PrecisionBiotics Group Ireland Pharmaceuticals, Food Complements ** 101039
18/06/2020 Le Noble Age (LNA Santé) Clinique Développement Seine-Maritime Clinics and hospitals * 100887
04/06/2020 Puig Charlotte Tilbury United Kingdom Personal Products * 101077
18/03/2020 Biogroup-LCD SCM Laborizon Hauts-De-Seine Medical Diagnostic Laboratory * 101055
02/03/2020 Private Group led by LBO France Dominique Dutscher Bas-Rhin Medical Supplies * 98460
14/01/2020 Heska Scil animal care company Germany Veterinary Pharmaceuticals, Diagnostic Medical Equipment * 98989
20/12/2019 Vivalto Santé Mathilde Médical Développement (MMD) France Clinics and hospitals * 101025
19/12/2019 Getinge Applikon Biotechnology Netherlands Medical Equipment ** 97683
30/11/2019 Private Group led by Omnes Capital Biofutur Val-D'Oise Medical Diagnostic Laboratory * 100831
30/10/2019 KOS Charleston Holding Germany Care Home *** 97631
29/10/2019 Dentressangle Marle International France Medical Implants or Prostheses Manufacturers ** 96851
08/10/2019 VAMED IHSS England Medical Supplies, Business Process Outsourcing (BPO) * 98096
26/09/2019 Groupe Léa Nature (Pharmaconcept Communication Developpement) Boho Green (Bo.Ho) Rhône Personal Products * 96391
06/08/2019 Sofina (Société Financière de Transports et d'Entreprises Industrielles) Drylock Technologies Belgium Personal Products, Baby and Childcare Products * 96011
05/08/2019 Cellink Cytena Germany Medical Equipment ** 95828
26/07/2019 Private Group Led by 3i Infrastructure Ionisos Ain Medical Equipment * 96547
13/07/2019 Knowlton Development Curzon Supplies (now: KDC/ONE Swallowfield) England Personal Products *** 100426
11/07/2019 Colgate-Palmolive Laboratories Filorga Cosmetiques Paris Personal Products ** 95502
25/06/2019 Private Group Led By FFP Financiere Acteon Gironde Medical Equipment * 97447
21/06/2019 Creightons Balance Active Formula Brand England Personal Products ** 98640
About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

EMAT Database
Epsilon Multiple Analysis Tool
The Reference Source for Private Company Acquisition Multiples

Test & Subscribe
EMAT Report

► Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).


► Example of EMAT Report